Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
EyePoint Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
EYPT
Nasdaq
2834
eyepointpharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for EyePoint Pharmaceuticals, Inc.
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Jun 16th, 2025 5:00 am
EyePoint Announces Participation at Upcoming Investor Conferences
- May 28th, 2025 2:01 pm
EyePoint Completes Enrollment in Pivotal Phase 3 LUGANO Trial of DURAVYUâ„¢ for Treatment of Wet Age-Related Macular Degeneration
- May 27th, 2025 5:00 am
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- May 16th, 2025 5:00 am
New Forecasts: Here's What Analysts Think The Future Holds For EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)
- May 11th, 2025 6:13 am
Earnings Beat: EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
- May 10th, 2025 6:11 am
EyePoint Pharmaceuticals (EYPT) Reports Q1 Earnings: What Key Metrics Have to Say
- May 7th, 2025 7:30 am
EyePoint Pharmaceuticals (EYPT) Reports Q1 Loss, Tops Revenue Estimates
- May 7th, 2025 6:25 am
EyePoint Pharmaceuticals: Q1 Earnings Snapshot
- May 7th, 2025 5:22 am
EyePoint Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Developments
- May 7th, 2025 5:00 am
EyePoint to Report First Quarter 2025 Financial Results on May 7, 2025
- Apr 30th, 2025 5:00 am
Here's Why We're Watching EyePoint Pharmaceuticals' (NASDAQ:EYPT) Cash Burn Situation
- Apr 2nd, 2025 4:44 am
EyePoint to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference
- Mar 27th, 2025 5:00 am
Despite Recent Gains, EyePoint Pharmaceuticals Insiders Are Still Down US$32k
- Mar 6th, 2025 3:34 am
EyePoint Pharmaceuticals Inc (EYPT) Q4 2024 Earnings Call Highlights: Navigating Challenges ...
- Mar 6th, 2025 12:06 am
EyePoint Pharmaceuticals (EYPT) Reports Q4 Earnings: What Key Metrics Have to Say
- Mar 5th, 2025 7:30 am
EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss, Lags Revenue Estimates
- Mar 5th, 2025 6:25 am
EyePoint Pharmaceuticals: Q4 Earnings Snapshot
- Mar 5th, 2025 5:34 am
EyePoint Reports Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Developments
- Mar 5th, 2025 5:00 am
EyePoint to Report Fourth Quarter and Full-Year 2024 Financial Results on March 5, 2025
- Feb 26th, 2025 5:00 am
Scroll